[
  {
    "ts": null,
    "headline": "Moderna, Inc. (MRNA) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript",
    "summary": "Moderna, Inc. (NASDAQ:MRNA) Goldman Sachs 46th Annual Global Healthcare Conference June 11, 2025 8:40 AM ETCompany ParticipantsStÃ©phane Bancel - CEO &amp;...",
    "url": "https://finnhub.io/api/news?id=fcafb7e6782a5bb79c593e4a7b24be636d44586179c8487fa8e31bb053bc2f1a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749674285,
      "headline": "Moderna, Inc. (MRNA) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript",
      "id": 135195650,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "MRNA",
      "source": "SeekingAlpha",
      "summary": "Moderna, Inc. (NASDAQ:MRNA) Goldman Sachs 46th Annual Global Healthcare Conference June 11, 2025 8:40 AM ETCompany ParticipantsStÃ©phane Bancel - CEO &amp;...",
      "url": "https://finnhub.io/api/news?id=fcafb7e6782a5bb79c593e4a7b24be636d44586179c8487fa8e31bb053bc2f1a"
    }
  },
  {
    "ts": null,
    "headline": "Transcript : Moderna, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 08",
    "summary": "Presenter SpeechSalveen Richter Great. Good morning, everyone. Thank you so much for joining us. Really pleased to have Stéphane Bancel, CEO of Moderna, with us.QuestionSalveen Richter Maybe to",
    "url": "https://finnhub.io/api/news?id=0e2561ef7fc81c2aa5ef62e648843d14fb98f3076c588e4dbc57d1f5d0fd7756",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749660628,
      "headline": "Transcript : Moderna, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 08",
      "id": 135194269,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Presenter SpeechSalveen Richter Great. Good morning, everyone. Thank you so much for joining us. Really pleased to have Stéphane Bancel, CEO of Moderna, with us.QuestionSalveen Richter Maybe to",
      "url": "https://finnhub.io/api/news?id=0e2561ef7fc81c2aa5ef62e648843d14fb98f3076c588e4dbc57d1f5d0fd7756"
    }
  },
  {
    "ts": null,
    "headline": "Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel",
    "summary": "Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly: VACCINE ADVISORY COMMITTEE: In an opinion article published by The Wall Street Journal, Robert F. Kennedy Jr. stated, “Vaccines have become a divisive issue in American politics, but there is one thing all parties can agree on: The U.S. faces a crisis of public trust. Whether toward health agenci",
    "url": "https://finnhub.io/api/news?id=0fb2c9884a3d968b1b0c30f15e468bdc5f7226238ff1a399f8ca9a402bd38ad7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749651653,
      "headline": "Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel",
      "id": 135184593,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly: VACCINE ADVISORY COMMITTEE: In an opinion article published by The Wall Street Journal, Robert F. Kennedy Jr. stated, “Vaccines have become a divisive issue in American politics, but there is one thing all parties can agree on: The U.S. faces a crisis of public trust. Whether toward health agenci",
      "url": "https://finnhub.io/api/news?id=0fb2c9884a3d968b1b0c30f15e468bdc5f7226238ff1a399f8ca9a402bd38ad7"
    }
  },
  {
    "ts": null,
    "headline": "Moderna to Present at Upcoming Barclays Speaking the Science Call Series on June 16, 2025",
    "summary": "CAMBRIDGE, MA / ACCESS Newswire / June 11, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor event: Barclays Speaking the Science Call Series, on Monday, June 16th at 10:00am ET A live webcast ...",
    "url": "https://finnhub.io/api/news?id=5118f930722c52314433c50da9a64e9d1eb69036faec4706c993b70fc5c96c05",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749639600,
      "headline": "Moderna to Present at Upcoming Barclays Speaking the Science Call Series on June 16, 2025",
      "id": 135180794,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "CAMBRIDGE, MA / ACCESS Newswire / June 11, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor event: Barclays Speaking the Science Call Series, on Monday, June 16th at 10:00am ET A live webcast ...",
      "url": "https://finnhub.io/api/news?id=5118f930722c52314433c50da9a64e9d1eb69036faec4706c993b70fc5c96c05"
    }
  },
  {
    "ts": null,
    "headline": "Kennedy Pledges to Immediately Replace Vaccine Advisors, Shortcutting Vetting Process",
    "summary": "Kennedy Pledges to Immediately Replace Vaccine Advisors, Shortcutting Vetting Process",
    "url": "https://finnhub.io/api/news?id=1a8b40c009049dc3fbeb37e53470cb3b375abd80403f1ecdfc0b866101e5696e",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749637200,
      "headline": "Kennedy Pledges to Immediately Replace Vaccine Advisors, Shortcutting Vetting Process",
      "id": 135405871,
      "image": "",
      "related": "MRNA",
      "source": "MarketWatch",
      "summary": "Kennedy Pledges to Immediately Replace Vaccine Advisors, Shortcutting Vetting Process",
      "url": "https://finnhub.io/api/news?id=1a8b40c009049dc3fbeb37e53470cb3b375abd80403f1ecdfc0b866101e5696e"
    }
  },
  {
    "ts": null,
    "headline": "Harbor Long-Short Equity ETF Q1 2025 Commentary",
    "summary": "During Q1 2025, the Harbor Long-Short Equity ETF returned 5.23% (NAV), outperforming its benchmark, the HRFX Equity Hedge Index, which returned 0.22%.",
    "url": "https://finnhub.io/api/news?id=4001480176008bbf4595c2c4c1a3084a811294b5079d7afe02aca435b6e56dce",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749635040,
      "headline": "Harbor Long-Short Equity ETF Q1 2025 Commentary",
      "id": 135180643,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2067714497/image_2067714497.jpg?io=getty-c-w1536",
      "related": "MRNA",
      "source": "SeekingAlpha",
      "summary": "During Q1 2025, the Harbor Long-Short Equity ETF returned 5.23% (NAV), outperforming its benchmark, the HRFX Equity Hedge Index, which returned 0.22%.",
      "url": "https://finnhub.io/api/news?id=4001480176008bbf4595c2c4c1a3084a811294b5079d7afe02aca435b6e56dce"
    }
  }
]